A detailed history of Brown Wealth Management, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Brown Wealth Management, LLC holds 50,248 shares of ALT stock, worth $359,273. This represents 0.11% of its overall portfolio holdings.

Number of Shares
50,248
Previous 50,000 0.5%
Holding current value
$359,273
Previous $333 Million 7.21%
% of portfolio
0.11%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.5 - $8.1 $1,364 - $2,008
248 Added 0.5%
50,248 $309 Million
Q1 2024

May 13, 2024

SELL
$8.22 - $13.81 $205,500 - $345,250
-25,000 Reduced 33.33%
50,000 $509 Million
Q4 2023

Feb 14, 2024

BUY
$2.14 - $11.62 $160,500 - $871,499
75,000 New
75,000 $844 Million

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $351M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Brown Wealth Management, LLC Portfolio

Follow Brown Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Wealth Management, LLC with notifications on news.